Search Results
274 results found for "VIB-VUB Center for Structural Biology"
- Adhesion GPCR Consortium Newsletter - May 2024
The distribution, functionality, and structure of the multiple splice isoforms that adhesion GPCRs possess I still remember entering the Hall at Boston ́s Children Hospital, going to register and being asked
- G protein-coupled receptor kinase type 2 and β-arrestin2: Key players in immune cell functions...
and the multifunctional scaffolding protein β-arrestin2 are key integrated signaling nodes in various biological
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
., Structural insights into differences in G protein activation by family A and family B GPCRs.
- Drug Discovery Picks Up the Pace, Stays on Target
technologies that stabilize G protein–coupled receptors (GPCRs) to enable the discovery of agonistic biologics
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
Biology of the Cell, 93(1‐2), 71-79. Wei, H., Ahn, S., Shenoy, S. K., Karnik, S.
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics
- VAMP2: a crucial player in the delivery of MOR to the synapse
You can consult the article at the following link: https://www.ecosystem.drgpcr.com/structural-and-molecular-insights-into-gpcr-function Struct. Mol. Biol. 15:658–664.
- Actions of Parathyroid Hormone Ligand Analogues in Humanized PTH1R Knockin Mice
Expression is directed by the endogenous mouse promoter and hence occurs in all biologically relevant
- Network pharmacological investigation into the mechanism of Kaixinsan powder for the treatment of...
enrichment analysis indicated that the mechanism of KXS in treating depression was involved in the biological
- Design and validation of recombinant protein standards for quantitative Western blot analysis of...
particular show a progressive tendency to aggregate and precipitate in aqueous solution outside of their biological
- Phospholipid Scrambling by G Protein-Coupled Receptors
Rapid flip-flop of phospholipids across the two leaflets of biological membranes is crucial for many
- Chemokine receptor-targeted drug discovery: progress and challenges
The involvement of chemokines and their receptors in several aspects of cancer biology, represents a
- Illuminating GPCR Research: FRET and BRET-Based Sensors Shed Light on Cellular Signaling
., BRET biosensors to study GPCR biology, pharmacology, and signal transduction.
- GASP1 enhances malignant phenotypes of breast cancer cells and decreases their response to...
However, its biological function and underlying molecular mechanism in breast cancer have not been clearly
- Coordinated transcriptomics and peptidomics of central nervous system identify neuropeptides and ...
Neuropeptides and their specific receptors (primarily G protein-coupled receptors, GPCRs) regulate multiple biological
- 📰 GPCR Weekly News, October 9 to 15, 2023
vitro pharmacology - Crinetics Pharmaceuticals In vivo Antibody Discovery Research Scientist In Vitro Biologist
- The Impact of CB1 Receptor on Nuclear Receptors in Skeletal Muscle Cells
It is as yet unknown whether these CB1 receptors contribute to pathways underlying skeletal muscle biological
- Amgen to Acquire Chemocentryx for $4 Billion in Cash
treat autoimmune diseases, inflammatory disorders and cancer, today announced that the companies have entered
- Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...
medicines for patients with central nervous system (CNS) disorders, today announced that the Company entered
- Exscientia is 10 years old this July!
have achieved a great deal in the last decade, such as the first-ever AI-designed drug candidates to enter
- Addex Raises $10 Million In Equity Financing
pioneering allosteric modulation-based drug discovery and development, today announced that it has entered
- Addex raises $4.2 million in equity financing
pioneering allosteric modulation-based drug discovery and development, today announced that it has entered